PL1661579T3 - Sposób leczenia układowego zakażenia bakteryjnego związanego ze zmianami jakościowymi i/lub ilościowymi kładu pozakomórkowego DNA krwi - Google Patents

Sposób leczenia układowego zakażenia bakteryjnego związanego ze zmianami jakościowymi i/lub ilościowymi kładu pozakomórkowego DNA krwi

Info

Publication number
PL1661579T3
PL1661579T3 PL04775224T PL04775224T PL1661579T3 PL 1661579 T3 PL1661579 T3 PL 1661579T3 PL 04775224 T PL04775224 T PL 04775224T PL 04775224 T PL04775224 T PL 04775224T PL 1661579 T3 PL1661579 T3 PL 1661579T3
Authority
PL
Poland
Prior art keywords
qualitative
changes
bacterial infection
quantitative composition
infection associated
Prior art date
Application number
PL04775224T
Other languages
English (en)
Inventor
Dmitry Dmitrievich Genkin
Victor Veniaminovich Tets
Georgy Victorovich Tets
Original Assignee
Cls Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/RU2003/000304 external-priority patent/WO2005007187A1/ru
Application filed by Cls Therapeutics Ltd filed Critical Cls Therapeutics Ltd
Publication of PL1661579T3 publication Critical patent/PL1661579T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/21—Endodeoxyribonucleases producing 5'-phosphomonoesters (3.1.21)
    • C12Y301/21001—Deoxyribonuclease I (3.1.21.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL04775224T 2003-07-14 2004-07-01 Sposób leczenia układowego zakażenia bakteryjnego związanego ze zmianami jakościowymi i/lub ilościowymi kładu pozakomórkowego DNA krwi PL1661579T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/RU2003/000304 WO2005007187A1 (en) 2003-07-14 2003-07-14 Method for treating oncological, virulent and somatic diseases, method for controlling treatment efficiency, pharmaceutical agents and composition for carrying out said treatment
RU2004108057/14A RU2269358C2 (ru) 2003-07-14 2004-03-12 Способ лечения генерализованных инфекций, вызываемых бактериями, или заболеваний, вызываемых грибами и простейшими, или атеросклероза, или сахарного диабета, или заболеваний, связанных с реакцией гиперчувствительности замедленного типа, или заболеваний, обусловленных мутациями генов соматических клеток
PCT/RU2004/000260 WO2005004789A2 (en) 2003-07-14 2004-07-01 Method for treating diseases associated with changes of qualitative and/ quantitative composition of blood extracellular dna
EP04775224A EP1661579B1 (en) 2003-07-14 2004-07-01 Method for treating systemic bacterial infection associated with changes of qualitative and/or quantitative composition of blood extracellular dna

Publications (1)

Publication Number Publication Date
PL1661579T3 true PL1661579T3 (pl) 2012-11-30

Family

ID=34067506

Family Applications (4)

Application Number Title Priority Date Filing Date
PL12170754T PL2497487T3 (pl) 2003-07-14 2004-07-01 Sposoby leczenia cukrzycy i miażdżycy naczyń krwionośnych związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi
PL04775224T PL1661579T3 (pl) 2003-07-14 2004-07-01 Sposób leczenia układowego zakażenia bakteryjnego związanego ze zmianami jakościowymi i/lub ilościowymi kładu pozakomórkowego DNA krwi
PL12170757T PL2497488T3 (pl) 2003-07-14 2004-07-01 Sposób leczenia reakcji nadwrażliwości typu opóźnionego związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi
PL12170750T PL2497486T3 (pl) 2003-07-14 2004-07-01 Sposoby leczenia chorób powodowanych przez grzyby i pierwotniaki, związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL12170754T PL2497487T3 (pl) 2003-07-14 2004-07-01 Sposoby leczenia cukrzycy i miażdżycy naczyń krwionośnych związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL12170757T PL2497488T3 (pl) 2003-07-14 2004-07-01 Sposób leczenia reakcji nadwrażliwości typu opóźnionego związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi
PL12170750T PL2497486T3 (pl) 2003-07-14 2004-07-01 Sposoby leczenia chorób powodowanych przez grzyby i pierwotniaki, związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi

Country Status (6)

Country Link
US (1) US20070104702A1 (pl)
EP (4) EP2497487B1 (pl)
ES (4) ES2388605T3 (pl)
PL (4) PL2497487T3 (pl)
RU (1) RU2269358C2 (pl)
WO (1) WO2005004789A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
US9248166B2 (en) 2003-07-14 2016-02-02 Cls Therapeutics Limited Method for treating oncological diseases
WO2006130034A1 (fr) 2005-04-25 2006-12-07 Dmitry Dmitrievich Genkin Procede pour prolonger la duree de vie d'animaux ou de l'humain
US8871200B2 (en) 2006-11-28 2014-10-28 Cls Therapeutics Limited Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method
EP2488160B1 (en) * 2009-10-16 2020-07-01 Lifecare Innovations Pvt. Ltd. Liposomal amphotericin formulation comprising cholesterol for treating fungal infections
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
ES2799515T3 (es) * 2015-05-22 2020-12-18 Dmitry Dmitrievich Genkin ADN extracelular como una diana terapéutica en la neurodegeneración
AU2019209770B2 (en) 2018-01-16 2025-07-31 Cls Therapeutics Limited Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4024530A1 (de) * 1990-08-02 1992-02-06 Klinger & Co Dr Verfahren zur bekaempfung von viren
FR2666096B1 (fr) * 1990-08-21 1993-12-31 Sfri Sa Nouveau procede de dosage d'acide desoxyribonucleique present en position extracellulaire dans un milieu.
US5484589A (en) * 1992-04-20 1996-01-16 Rufeld, Inc. Anti-viral methods using RNAse and DNAse
NZ331063A (en) * 1996-02-05 2000-03-27 Inc Genentech Isolated nucleotide sequences encoding for mature LS- DNase which is resistant to actin inhibition
US6391607B1 (en) * 1996-06-14 2002-05-21 Genentech, Inc. Human DNase I hyperactive variants
AU2003298972A1 (en) * 2003-07-14 2005-02-04 Dmitry Dmitrievich Genkin Method for treating oncological, virulent and somatic diseases, method for controlling treatment efficiency, pharmaceutical agents and composition for carrying out said treatment

Also Published As

Publication number Publication date
PL2497487T3 (pl) 2014-01-31
ES2388605T3 (es) 2012-10-16
EP1661579B1 (en) 2012-06-06
RU2269358C2 (ru) 2006-02-10
PL2497486T3 (pl) 2014-01-31
ES2433918T3 (es) 2013-12-13
PL2497488T3 (pl) 2014-01-31
WO2005004789A3 (en) 2005-03-24
ES2434112T3 (es) 2013-12-13
EP2497488A1 (en) 2012-09-12
ES2434111T3 (es) 2013-12-13
EP1661579A4 (en) 2009-11-25
EP2497486B1 (en) 2013-08-07
WO2005004789A2 (en) 2005-01-20
EP1661579A2 (en) 2006-05-31
US20070104702A1 (en) 2007-05-10
EP2497488B1 (en) 2013-08-07
EP2497487B1 (en) 2013-08-07
EP2497486A1 (en) 2012-09-12
EP2497487A1 (en) 2012-09-12
RU2004108057A (ru) 2005-09-27

Similar Documents

Publication Publication Date Title
DE60303572D1 (de) Katheter und Verfahren zur Darstellung von Purkinje-Fasern
EP1643893A4 (en) PROCESS FOR DETECTING GENTRANSCROSS IN BLOOD AND ITS USES
AU2002233643A1 (en) Methods of treating diseases in association with decrease in the expression of AOP-1 gene or AOP-1 and remedies for the diseases
AU2003233451A8 (en) Targets, methods, and reagents for diagnosis and treatment of schizophrenia
AU2003300053A1 (en) Multi-chamber treatment apparatus and method
EP1531828A4 (en) METHODS OF TREATING BACTERIAL INFECTIONS AND ASSOCIATED DISEASES
EP1613334A4 (en) ALCOHOL-FREE TRANSDERMAL INSULIN COMPOSITION AND METHOD FOR THE PRODUCTION AND USE THEREOF
AU2002231095A1 (en) Method and composition for the treatment of diabetic neuropathy
PL1661579T3 (pl) Sposób leczenia układowego zakażenia bakteryjnego związanego ze zmianami jakościowymi i/lub ilościowymi kładu pozakomórkowego DNA krwi
AU2002312211A1 (en) Methods and reagents for diagnosis and treatment of insulin resistance and related conditions
EP1468005A4 (en) METHODS OF USING SACCHARIDE CONJUGATES AND ACETAMIDINE OR GUANIDINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
WO2003087325A3 (en) Methods and compositions for preventing and treating microbial infections
WO2005030131A3 (en) Bis-quinazoline compounds for the treatment of bacterial infections
FI20031678A0 (fi) Näytteen käsittelymenetelmä ja järjestely siihen
AU2003244132A8 (en) Method of examining allergic disaese and drug for treating the same
AU2002367706A1 (en) Method and apparatus for analyizing biological tissue specimens
EP1824462A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF TAUOPATHIES
DE602004004708D1 (de) Vorrichtung und Verfahren zur Bestimmung von Bakterien
AU2003237870A8 (en) Method and composition for inhibing or slowing blood coagulation
AU2003228787A8 (en) Composition and method for reducing post-prandial blood glucose
FI20010352A0 (fi) Menetelmä bakteerien ja bakteeriryhmien osoittamiseksi
AU2003907034A0 (en) Method of biological control of skin infections and defects
HK1094952A (en) System and method for increasing concentration of sterilant in region
HK1093448A (en) System and method for determining concentration of sterilant
SE0301724D0 (sv) Substances for use in the treatment of beta-cell dependent diabetes, methods and kits for identifying the substances